Ambrobene solution 7.5mg / ml, 40 ml
Expiration Date: 05/2027
Russian Pharmacy name:
Амбробене раствор 7.5мг/мл, 40 мл
Acute and chronic diseases of the respiratory tract, accompanied by a violation of the formation and discharge of sputum.
Inside, inhalation, IV.
The duration of treatment is selected individually, depending on the course of the disease. It is not recommended to take Ambrobene without a doctor's prescription for more than 4-5 days.
The mucolytic effect of the drug is manifested when a large amount of liquid is taken. Therefore, during treatment, it is recommended to drink plenty of fluids.
Pills
Inside, after eating, swallowing whole without chewing, drinking plenty of liquid.
Children from 6 to 12 years old: 1/2 tab. 2-3 times a day (15 mg ambroxol 2-3 times a day).
Adults and children over 12 years old: in the first 2-3 days of treatment - 1 table. 3 times a day (30 mg ambroxol 3 times a day). If therapy is ineffective, adults can increase the dose to 2 tablets. 2 times a day (120 mg ambroxol per day). On the following days, you should take 1 table. 2 times a day (30 mg ambroxol 2 times a day).
Sustained-release capsules
Inside, after eating, swallowing whole without chewing, drinking plenty of liquid.
Adults and children over 12 years old: 1 caps. per day (75 mg of ambroxol per day).
Syrup
Inside, after meals, using the supplied measuring cup.
Children: up to 2 years old - 1/2 measuring cup (2.5 ml of syrup) 2 times a day (15 mg of ambroxol per day); from 2 to 6 years - 1/2 measuring cup (2.5 ml of syrup) 3 times a day (22.5 mg of ambroxol per day); from 6 to 12 years old - 1 measuring cup (5 ml of syrup) 2-3 times a day (30-45 mg of ambroxol per day).
Adults and children over 12 years of age: in the first 2-3 days of treatment - 2 measuring cups (10 ml of syrup) 3 times a day (90 mg of Ambroxol per day). If therapy is ineffective, adults can increase the dose to 4 measuring cups (20 ml of syrup) 2 times a day (120 mg of ambroxol per day). On the following days, you should take 2 measuring cups (10 ml of syrup) 2 times a day (60 mg of ambroxol per day).
Solution for oral administration and inhalation
Inside, after meals, adding to water, juice or tea using the supplied measuring cup.
Children: up to 2 years old - 1 ml of the drug 2 times a day (15 mg of ambroxol per day); from 2 to 6 years - 1 ml of the drug 3 times a day (22.5 mg of ambroxol per day); from 6 to 12 years old - 2 ml of the drug 2-3 times a day (30-45 mg of ambroxol per day).
Adults and children over 12 years of age: in the first 2-3 days of treatment - 4 ml of the drug 3 times a day (90 mg of Ambroxol per day). If therapy is ineffective, adults can increase the dose to 8 ml of the drug 2 times a day (120 mg ambroxol per day). On the following days, you should take 4 ml of the drug 2 times a day (60 mg of Ambroxol per day).
Inhalation When using the drug Ambrobene in the form of inhalation, you can use any modern equipment (except for steam inhalers). Before inhalation, the drug is mixed with 0.9% sodium chloride solution (for optimal air humidification, it can be diluted in a 1: 1 ratio) and heated to body temperature. Since during inhalation therapy, a deep breath can provoke cough tremors, inhalations should be carried out in a normal breathing mode. Patients with bronchial asthma can be advised to carry out inhalation after taking bronchodilators.
1 ml of solution contains 7.5 mg of ambroxol.
Children: up to 2 years old - 1 ml of solution 1-2 times a day (7.5-15 mg of ambroxol per day); from 2 to 6 years - 2 ml of solution 1-2 times a day (15-30 mg of ambroxol per day).
Adults and children over 6 years old: 2-3 ml of solution 1-2 times a day (15-45 mg of ambroxol per day).
Intravenous solution
IV, slow, jet or drip. The solvent used is 0.9% sodium chloride solution, 5% glucose solution, Ringer-Locke's solution or other basic solution with a pH not higher than 6.3.
The daily dose is 30 mg / kg, evenly distributed over 4 injections per day.
The solution should be injected intravenously, slowly, for at least 5 minutes.
Injections are stopped after the disappearance of acute manifestations of the disease and are switched to oral administration of other dosage forms of the drug.
Pills | 1 tab. |
active substance: | |
ambroxol hydrochloride | 30 mg |
excipients: lactose monohydrate; corn starch; magnesium stearate; anhydrous colloidal silicon dioxide |
Sustained-release capsules | 1 caps. |
active substance: | |
ambroxol hydrochloride | 75 mg |
excipients: MCC (PH 102); MCC (PC 581); hypromellose (Pharmacoat 603); methacrylic acid and ethyl acrylate copolymer (1: 1); triethyl citrate; anhydrous colloidal silicon dioxide | |
capsule shell: cap - gelatin, iron dye yellow oxide (E172), iron dye black oxide (E172), iron dye red oxide (E172), titanium dioxide; body - gelatin |
Syrup | 100 ml |
active substance: | |
ambroxol hydrochloride | 0.3 g |
excipients: liquid sorbitol 70%; propylene glycol; raspberry flavor; saccharin; purified water |
Solution for oral administration and inhalation | 100 ml |
active substance: | |
ambroxol hydrochloride | 0.75 g |
excipients: potassium sorbate - 0.1 g; hydrochloric acid (25%) - 0.06 g; purified water - 99.19 g |
Intravenous solution | 2 ml |
active substance: | |
ambroxol hydrochloride | 15 mg |
excipients: citric acid monohydrate - 1.8 mg; sodium chloride - 13.6 mg; sodium hydrogen phosphate heptahydrate - 4.7 mg; water for injection - 1979.9 mg |
hypersensitivity to ambroxol or one of the excipients;
pregnancy (I trimester).
Additionally for tablets
children under 6 years of age;
lactose intolerance, lactase deficiency, glucose-galactose malabsorption.
Additionally for extended-release capsules
children under 12 years of age.
Additionally for syrup
deficiency of sucrase / isomaltase, fructose intolerance, glucose-galactose malabsorption.
With caution: impaired motor function of the bronchi and increased production of sputum (with immobile cilia syndrome), pregnancy (II Ц III trimester), lactation - for all dosage forms; peptic ulcer of the stomach and duodenum during an exacerbation - for oral dosage forms.
Patients with impaired renal function or severe liver disease should take Ambrobene with extreme caution, observing longer intervals between doses or taking the drug at a lower dose.